"Indiana University Building a Medical Device Security Lab With TriMedX"

Indiana University Health is collaborating with TriMedX to establish a new cybersecurity lab that will assess and test the security of medical devices in the hopes of reducing cybersecurity threats during the device development process. TriMedX, specializing in clinical engineering and clinical asset management, will bring its technology expertise to Indiana University Health's medical device security lab, where there will be collaborative efforts on testing medical devices for security vulnerabilities and interoperability. The company has data on 92 percent of all active medical device models. The security lab's goal is to test the medical equipment in a risk-free environment for patients. Cyber researchers will evaluate new devices before they are implemented in hospitals. In addition, they will test configurations and security setups to determine which services must be turned on and which ports must be available on the network to ensure operational safety. They will also scan security testing equipment with no live impact on the network or patients. Both organizations say the goal is to eventually share these capabilities with other health systems. According to Indiana University Health and TriMedX, nearly 70 percent of medical devices will be connected by 2025. Meanwhile, reports show that hospitals continue to struggle with their Internet of Things (IoT) device security strategies. In one recent survey, over half of the respondents said their healthcare organizations had one or more cyberattacks involving connected medical devices in the previous 24 months, many of which, the FBI warns, are outdated. This article continues to discuss the collaboration between Indiana University Health and TriMedX to build a medical device security lab aimed at helping healthcare organizations remediate vulnerabilities before equipment reaches the patient floor.

HealthcareITNews reports "Indiana University Building a Medical Device Security Lab With TriMedX"